CVRx (CVRX) Debt Ratio (2020 - 2026)

CVRx (CVRX) posted Debt Ratio of 0.63 for Q2 2026, up 8.22% on a QoQ basis from 0.59 in Q1 2026, and up 53.64% year-over-year from 0.41 in Q2 2025.

Analysis

CVRx (CVRX) Debt Ratio (2020 - 2026) Analysis & Trends

CVRx has reported Debt Ratio for 7 years, with the latest figure at 0.63 in Q2 2026.

On a quarterly basis, Debt Ratio rose 53.64% year-over-year to 0.63 in Q2 2026; TTM through Jun 2026 was 0.63, a 53.64% increase from a year earlier, with the FY2025 full-year figure at 0.47, up 27.93% from the prior year.
Debt Ratio was 0.63 for Q2 2026 at CVRx, up from 0.59 in the prior quarter.
The five-year high for Debt Ratio was 0.63 in Q2 2026, with the low at 0.05 in Q4 2022.
Average Debt Ratio over 5 years is 0.33, with a median of 0.37 recorded in 2024.
The sharpest annual moves came in 2023 and 2025: Debt Ratio surged 369.6% in 2023, then grew 15.24% in 2025.
Over 5 years, Debt Ratio stood at 0.05 in 2022, then soared by 369.6% to 0.25 in 2023, then surged by 45.63% to 0.37 in 2024, then advanced by 27.93% to 0.47 in 2025, then soared by 34.33% to 0.63 in 2026.
The last three Debt Ratio figures came in at 0.63 (Q2 2026), 0.59 (Q1 2026), and 0.47 (Q4 2025), per Business Quant data.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Abbott Laboratories	183.04 Bn	177.44 Bn	7.27 Bn	0.30
2	Intuitive Surgical	125.02 Bn	119.81 Bn	1.96 Bn	-
3	Medtronic	117.84 Bn	109.02 Bn	6.34 Bn	0.30
4	Stryker	105.50 Bn	102.02 Bn	4.50 Bn	0.31
5	Boston Scientific	66.27 Bn	65.73 Bn	3.85 Bn	0.28
6	Edwards Lifesciences	49.60 Bn	45.35 Bn	1.35 Bn	0.04
7	Alcon	33.70 Bn	32.24 Bn	1.68 Bn	0.13
8	Dexcom	32.06 Bn	30.11 Bn	830.00 Mn	-
9	Steris	21.02 Bn	20.54 Bn	684.20 Mn	0.20
10	CVRx	75.57 Mn	10.98 Mn	13.72 Mn	0.63

Historic Data

Download Data